ctrl K

Price Alert

Aquestive Therapeutics In... (AQST)

NASDAQ: AQST · Real-Time Price · USD

4.13

0.02 (0.49%)

At close: Aug 15, 2025, 3:59 PM

Aquestive Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	71.55M	23.87M	27.27M	28.02M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	3M	4M	5M	6M
Other Long-Term Assets	1.22M	1.44M	6.45M	6.9M
Receivables	7.34M	8.47M	4.7M	12.12M
Inventory	6.04M	6.77M	5.78M	4.04M
Other Current Assets	3.29M	1.85M	2.13M	n/a
Total Current Assets	88.22M	40.97M	39.89M	47.26M
Property-Plant & Equipment	8.98M	9.74M	7.9M	7.78M
Goodwill & Intangibles	n/a	1.28M	1.44M	51K
Total Long-Term Assets	13.2M	16.45M	15.79M	14.73M
Total Assets	101.42M	57.42M	55.67M	61.99M
Account Payables	10.29M	8.93M	9.95M	8.31M
Deferred Revenue	1.05M	1.55M	1.51M	765K
Short-Term Debt	26K	22K	18.7M	2.02M
Other Current Liabilities	1M	5.12M	7.69M	7.19M
Total Current Liabilities	18.86M	18.31M	39.68M	21.96M
Long-Term Debt	32.5M	27.51M	33.45M	51.55M
Other Long-Term Liabilities	85.24M	80.34M	66.15M	2.48M
Total Long-Term Liabilities	142.72M	145.6M	136.1M	122.16M
Total Liabilities	161.58M	163.91M	174.23M	144.13M
Total Debt	38M	33.32M	57.49M	56.42M
Common Stock	91K	69K	55K	41K
Retained Earnings	-363.21M	-319.08M	-311.21M	-256.8M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	-60.16M	-106.49M	-118.55M	-82.13M
Total Investments	3M	4M	5M	6M